Ovarian cancer incidence and death in average-risk women undergoing bilateral salpingo-oophorectomy at benign hysterectomy

被引:15
作者
Cusimano, Maria C. [1 ,2 ,3 ]
Ferguson, Sarah E. [1 ,4 ,5 ]
Moineddin, Rahim [6 ,7 ,8 ]
Chiu, Maria [2 ,6 ]
Aktar, Suriya [6 ]
Liu, Ning [6 ]
Baxter, Nancy N. [2 ,3 ,6 ,9 ,10 ]
机构
[1] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON, Canada
[2] Univ Toronto, Dalla Lana Sch Publ Hlth, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
[3] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada
[4] Princess Margaret Canc Ctr, Div Gynecol Oncol, Toronto, ON, Canada
[5] Sinai Hlth Syst, Toronto, ON, Canada
[6] ICES, Toronto, ON, Canada
[7] Univ Toronto, Dalla Lana Sch Publ Hlth, Biostat Div, Toronto, ON, Canada
[8] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada
[9] Univ Toronto, Dept Surg, Toronto, ON, Canada
[10] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia
基金
加拿大健康研究院;
关键词
gynecologic surgical procedures; hysterectomy; ovarian cancer; ovariectomy; IN-HOSPITAL-COMPLICATIONS; PROPENSITY SCORE METHODS; PROPHYLACTIC OOPHORECTOMY; LONG-TERM; SEXUAL FUNCTION; CONSERVATION; ANDROGEN; SURVIVAL; HEALTH; TIME;
D O I
10.1016/j.ajog.2021.09.020
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: Opportunistic bilateral salpingo-oophorectomy is often offered to patients undergoing benign hysterectomy to prevent ovarian cancer, but the magnitude of risk reduction obtained with bilateral salpingo-oophorectomy in this population remains unclear and must be weighed against potential risks of ovarian hormone deficiency. OBJECTIVE: This study aimed to quantify the relative and absolute risk reduction in ovarian cancer incidence and death associated with bilateral salpingo-oophorectomy at the time of benign hysterectomy. STUDY DESIGN: We performed a population-based cohort study of all adult women (>= 20 years) undergoing benign hysterectomy from 1996 to 2010 in Ontario, Canada. Patients with ovarian pathology, previous breast or gynecologic cancer, or evidence of genetic susceptibility to malignancy were excluded. Inverse probability of treatment-weighted Fine-Gray subdistribution hazard models were used to quantify the effect of bilateral salpingo-oophorectomy on ovarian cancer incidence and death while accounting for competing risks and adjusting for demographic characteristics, gynecologic conditions, and comorbidities. Analyses were performed in all women and specifically in women of postmenopausal age (>= 50 years) at the time of hysterectomy. RESULTS: We identified 195,282 patients (bilateral salpingo-oophorectomy, 24%; ovarian conservation, 76%) with a median age of 45 years (interquartile range, 40-51 years). Over a median follow-up of 16 years (interquartile range, 12-20 years), 548 patients developed ovarian cancer (0.3%), and 16,170 patients (8.3%) died from any cause. Bilateral salpingo-oophorectomy was associated with decreased ovarian cancer incidence (hazard ratio, 0.23; 95% confidence interval, 0.14-0.38; P<.001) and decreased ovarian cancer death (hazard ratio, 0.30; 95% confidence interval, 0.16-0.57; P<.001). At 20 years follow-up, the weighted cumulative incidences of ovarian cancer were 0.08% and 0.46% with bilateral salpingo-oophorectomy and ovarian conservation, respectively, yielding an absolute risk reduction of 0.38% (95% confidence interval, 0.32-0.45; number needed to treat, 260). After restricting to women aged >= 50 years at hysterectomy, the absolute risk reduction was 0.62% (95% confidence interval, 0.47-0.77; number needed to treat, 161). CONCLUSION: Bilateral salpingo-oophorectomy resulted in a significant absolute reduction in ovarian cancer among women undergoing benign hysterectomy. Population-average risk estimates derived in this study should be balanced against other potential implications of bilateral salpingo-oophorectomy to inform practice guidelines, patient decision-making, and surgical management.
引用
收藏
页数:26
相关论文
共 50 条
[41]   Specifying the ovarian cancer risk threshold of "premenopausal risk-reducing salpingo-oophorectomy' for ovarian cancer prevention: a cost-effectiveness analysis [J].
Manchanda, Ranjit ;
Legood, Rosa ;
Antoniou, Antonis C. ;
Gordeev, Vladimir S. ;
Menon, Usha .
JOURNAL OF MEDICAL GENETICS, 2016, 53 (09) :591-599
[42]   The role of peritoneal cytology at risk-reducing salpingo-oophorectomy (RRSO) in women at increased risk of familial ovarian/tubal cancer [J].
Manchanda, Ranjit ;
Drapkin, Ronny ;
Jacobs, Ian ;
Menon, Usha .
GYNECOLOGIC ONCOLOGY, 2012, 124 (02) :185-191
[43]   Ovarian-conserving surgery versus bilateral oophorectomy in patients undergoing hysterectomy for benign processes [J].
Gallo Vallejo, J. L. .
CLINICA E INVESTIGACION EN GINECOLOGIA Y OBSTETRICIA, 2009, 36 (03) :94-98
[44]   Fatigue and Quality of Life After Risk-Reducing Salpingo-Oophorectomy in Women at Increased Risk for Hereditary Breast-Ovarian Cancer [J].
Michelsen, Trond M. ;
Dorum, Anne ;
Trope, Claes G. ;
Fossa, Sophie D. ;
Dahl, Alv A. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (06) :1029-1036
[45]   Impact of incidental bilateral salpingo-oophorectomy in a family member on breast cancer risk assessment: Clinical considerations [J].
Salant, Talya ;
Lauderdale, Diane S. .
CANCER DETECTION AND PREVENTION, 2006, 30 (04) :329-332
[46]   Effects of bilateral salpingo-oophorectomy at the time of hysterectomy on pelvic organ prolapse: results from the Women's Health Initiative trial [J].
Shveiky, David ;
Kudish, Bela I. ;
Iglesia, Cheryl B. ;
Park, Amy J. ;
Sokol, Andrew I. ;
Lehman, Amy M. ;
Shara, Nawar ;
Howard, Barbara V. .
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (05) :483-488
[47]   Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis [J].
Manchanda, R. ;
Burnell, M. ;
Abdelraheim, A. ;
Johnson, M. ;
Sharma, A. ;
Benjamin, E. ;
Brunell, C. ;
Saridogan, E. ;
Gessler, S. ;
Oram, D. ;
Side, L. ;
Rosenthal, A. N. ;
Jacobs, I. ;
Menon, U. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2012, 119 (05) :527-536
[48]   Hormone therapy after prophylactic risk-reducing bilateral salpingo-oophorectomy in women who have BRCA gene mutation [J].
Guidozzi, F. .
CLIMACTERIC, 2016, 19 (05) :419-422
[49]   Short-term impact of surgically induced menopause on cognitive function and wellbeing in women at high risk for ovarian cancer following risk-reducing bilateral salpingo-oophorectomy [J].
Chang, Heidi ;
Kamara, Daniella ;
Bresee, Catherine ;
Lester, Jenny ;
Cass, Ilana .
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2021, 28 (04) :354-359
[50]   Use of total abdominal hysterectomy and hormone replacement therapy in BRCA1 and BRCA2 mutation carriers undergoing risk-reducing salpingo-oophorectomy [J].
Gabriel, C. A. ;
Tigges-Cardwell, J. ;
Stopfer, J. ;
Erlichman, J. ;
Nathanson, K. ;
Domchek, S. M. .
FAMILIAL CANCER, 2009, 8 (01) :23-28